期刊文献+

注射用尤瑞克林治疗急性脑梗死40例临床观察

暂未订购
导出
摘要 目的探讨注射用尤瑞克林治疗急性脑梗死的疗效。方法 75例急性脑梗死患者随机分为治疗组40例和对照组35例。对照组采用基础治疗,治疗组在对照组基础上给予0.9%生理盐水200 ml+尤瑞克林0.15 PNA单位静脉滴注,1次/d,疗程10 d。治疗前,治疗后10 d和30d进行NI HSS评分和Barthel指数评分。结果治疗组和对照组间治疗后10 d和30 d NI HSS评分、Barthel指数评分的差异均有统计学意义(均P<0.01)。结论注射用尤瑞克林治疗急性脑梗死,近期效果及远期效果均较为明显,且安全、有效。
作者 翁元焦 陈敏
出处 《福建医药杂志》 CAS 2011年第3期50-51,共2页 Fujian Medical Journal
  • 相关文献

参考文献7

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 2邵京山,严志敏,冯玉兰,赵静,蒋爱华,翁迎峰,徐晓英.尤瑞克林与依达拉奉治疗急性颈内动脉系统缺血性卒中的临床对比研究[J].中国卒中杂志,2010,5(6):459-462. 被引量:11
  • 3Plendl J, Snyman C, Naidoo S, et al. Expression of tissue kal likrein and kinin receptors in angiogenic microvascular endothelial cells [J]. Biolchem, 2000, 381 (11): 1103-1115.
  • 4Campbell DJ. The kallik rein-kinin system in humans [J]. Clin Exp Pharmacol Physiol, 2001, 28 (12) : 1060-1065.
  • 5Ling L, Hou Q, Xing S, et al. Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region andimproves neurological function after focal cortical infarction in hypertensive rats [J]. Brain Res, 2008, 1206, 89-97.
  • 6Xia CF, Yin H, Yao YY, et al. Kallikrein protects against is- chemic stroke by inhibiting apoptosis and inflammation and pro-rooting angiogenesis and neurogenesis [J]. Hum Gene Ther. 2006 , 17 (2): 206-219.
  • 7Wagner S, Kalb P, Lukosava M, et al. Activation of the tissue kallikrein-kinin system in stroke [J]. J Neurol Sci. 2002, 202 (1):75-76.

二级参考文献11

  • 1狄晴,葛剑青,陈道文,徐肖,陈惠玲,过燕萍,李继民,石静萍,张颖冬,李作汉.依达拉奉治疗急性脑梗死的临床观察[J].临床神经病学杂志,2004,17(3):184-186. 被引量:304
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 3凌莉,曾进胜.激肽释放酶-激肽系统与脑缺血[J].国际脑血管病杂志,2007,15(2):148-152. 被引量:7
  • 4Xia CF,Yin H,Borlongan CV,et al.Killikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apopttosis[J].Hypertension,2004,43:452-459.
  • 5Edaravone Acute Infarction Study Group.Effect of a novel free radical scavenger,edaravone (MCI-186),on acute brain infarction.Randomized,placebocontrolled,double-blind study at multicenters[J].Cerebrovasc Dis,2003,15:222-229.
  • 6Watanabe T,Tanaka M,Watanabe K,et al.Research and development of the free radical scavenger edaravone as a neuroprotectant[J].Yakuguka Zasshi,2004,124:99-111.
  • 7Nagano H,Suzuki T,Tomoguri T,et al.Pharmacological studies on human urinary kallidinogenase (SK-827):effects on cerebral metabolism[J].Yakugaku Zasshi,1993,113:825-828.
  • 8Plendl J,Snyman C,Naidoo S,et al.Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells[J].Biol chem,2000,381:1103-1115.
  • 9Ling L,Hou Q,Xing S,et al.Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats[J].Brian Res,2008,1206:89-97.
  • 10Campbell DJ.The kallikrein-kinin system in humans[J].Clin Exp Pharmacol Physiol,2001,28:1060-1065.

共引文献33101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部